Sansure Biotech Inc. Class ASSE: 688289

Announcement on Convening the Q3 2025 Performance Briefing

· Issued by Sansure Biotech Inc. Class A via Shanghai Stock Exchange
Announcement on Convening the Q3 2025 Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment